CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) was the target of a significant increase in short interest during the month of October. As of October 30th, there was short interest totaling 160,001 shares, an increase of 16,000,000.0% from the October 15th total of 1 shares. Based on an average daily volume of 31,920,948 shares, the days-to-cover ratio is currently 0.0 days.
CNBX Pharmaceuticals Price Performance
CNBX Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.00.
CNBX Pharmaceuticals Company Profile
CNBX Pharmaceuticals, Inc. is a biotechnology company focused on developing cannabinoid-based pharmaceutical products and treatments. Its research has centered on the potential use of medical cannabis compounds in oncology and other therapeutic applications. The company has worked on technologies designed to evaluate how individual cancer cells respond to different cannabinoid formulations. Its development activities have included cannabinoid-based oral products and personalized-treatment approaches intended to help identify potentially effective therapies for specific patients.
Further Reading
- Five stocks we like better than CNBX Pharmaceuticals
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for CNBX Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNBX Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
